期刊(kan)中文名:Infektsiya I 免疫ISSN:2220-7619E-ISSN:2313-7398
該雜志(zhi)國際簡稱:INFEKTSIYA IMMUN,是由(you)出版商Sankt-Peterburg : NIIèM imeni Pastera出版的一本(ben)致力于發(fa)布(bu)--研(yan)究新(xin)成果的的專業學(xue)術(shu)(shu)期(qi)刊。主要發(fa)表刊登有創見的學(xue)術(shu)(shu)論(lun)文文章、行(xing)業最新(xin)科研(yan)成果,扼要報道階段性研(yan)究成果和重要研(yan)究工作(zuo)的最新(xin)進展,選載對學(xue)科發(fa)展起(qi)指(zhi)導(dao)作(zuo)用(yong)的綜(zong)述與專論(lun),促進學(xue)術(shu)(shu)發(fa)展,為廣大讀(du)者服務。該刊是一本(ben)國際優秀雜志(zhi),在國際上有很高的學(xue)術(shu)(shu)影響力。
《Infektsiya I Immunitet》是一本以(yi)Russian為主的(de)(de)開放獲取(qu)國(guo)際優秀(xiu)期刊(kan),中文名稱Infektsiya I 免疫,本刊(kan)主要(yao)出版(ban)、報道(dao)領域的(de)(de)研究動態以(yi)及(ji)在該(gai)領域取(qu)得(de)的(de)(de)各(ge)方面的(de)(de)經驗(yan)和(he)科研成果,介紹(shao)該(gai)領域有關本專(zhuan)業(ye)的(de)(de)最(zui)新進展(zhan),探討行業(ye)發(fa)展(zhan)的(de)(de)思路和(he)方法,以(yi)促進學術信(xin)息交流(liu),提高(gao)行業(ye)發(fa)展(zhan)。該(gai)刊(kan)已(yi)被國(guo)際權(quan)威數據庫(ku)SCIE收錄,為該(gai)領域相關學科的(de)(de)發(fa)展(zhan)起(qi)到了良好的(de)(de)推動作(zuo)用,也得(de)到了本專(zhuan)業(ye)人員的(de)(de)廣(guang)泛認(ren)可。該(gai)刊(kan)最(zui)新影(ying)響因子為0.2,最(zui)新CiteScore 指數為1.4。
Infektsiya i Immunity "is a scientific journal dedicated to the fields of infectious diseases and immunology. This magazine publishes research articles on pathogens, host reactions, vaccine development, anti infective therapies, and immune regulatory mechanisms. It aims to provide a platform for medical researchers, clinical doctors, and public health experts to discuss the latest research findings and clinical practices.
The characteristics of this journal lie in its in-depth exploration of infectious diseases and immunology, as well as its focus on emerging infectious diseases and immunotherapy. The academic positioning of this journal is to become an authoritative publication in the field, promoting the development of scientific research and medical practice. Infektsiya i Immuntaeta is of great significance to researchers and clinical doctors in the fields of infectious diseases and immunology. It not only provides a platform for publishing the latest research findings, but also helps guide clinical decision-making and the development of public health strategies, having a positive impact on improving global health levels.
按JIF指標學科分區 |
學科:INFECTIOUS DISEASES
收錄子集:ESCI
分區:Q4
排名:128 / 132
百分位:
3.4% |
按JCI指標(biao)學科分區 |
學科:INFECTIOUS DISEASES
收錄子集:ESCI
分區:Q4
排名:128 / 132
百分位:
3.41% |
JCR分區:JCR分(fen)(fen)區(qu)來自(zi)科睿唯安公司,JCR是一(yi)個(ge)(ge)獨(du)特(te)的(de)(de)多學(xue)科期刊(kan)(kan)評價(jia)工具,為唯一(yi)提供(gong)基于引文(wen)數(shu)據(ju)的(de)(de)統計信息(xi)的(de)(de)期刊(kan)(kan)評價(jia)資源。每年(nian)發布的(de)(de)JCR分(fen)(fen)區(qu),設置了254個(ge)(ge)具體學(xue)科。JCR分(fen)(fen)區(qu)根據(ju)每個(ge)(ge)學(xue)科分(fen)(fen)類(lei)按照期刊(kan)(kan)當年(nian)的(de)(de)影響因子(zi)高(gao)低將期刊(kan)(kan)平均分(fen)(fen)為4個(ge)(ge)區(qu),分(fen)(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)區(qu)中期刊(kan)(kan)的(de)(de)數(shu)量是均勻分(fen)(fen)為四個(ge)(ge)部(bu)分(fen)(fen)的(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Infectious Diseases | Q4 | 264 / 344 |
23% |
大類:Medicine 小類:Immunology and Allergy | Q4 | 185 / 233 |
20% |
大類:Medicine 小類:Immunology | Q4 | 204 / 236 |
13% |
該(gai)雜(za)(za)志(zhi)是一(yi)(yi)本(ben)國(guo)際(ji)優(you)秀雜(za)(za)志(zhi),在國(guo)際(ji)上有較(jiao)(jiao)高(gao)的學術影響力,行業關注度很高(gao),已被國(guo)際(ji)權威數據庫SCIE收錄,該(gai)雜(za)(za)志(zhi)在綜合專(zhuan)業領域專(zhuan)業度認可很高(gao),對稿(gao)(gao)(gao)件內容(rong)的創(chuang)新(xin)性和學術性要求(qiu)很高(gao),作為一(yi)(yi)本(ben)國(guo)際(ji)優(you)秀雜(za)(za)志(zhi),一(yi)(yi)般投(tou)(tou)稿(gao)(gao)(gao)過(guo)審時(shi)間(jian)都(dou)較(jiao)(jiao)長,投(tou)(tou)稿(gao)(gao)(gao)過(guo)審時(shi)間(jian)平均 10 Weeks ,如果想(xiang)(xiang)投(tou)(tou)稿(gao)(gao)(gao)該(gai)刊要做好(hao)時(shi)間(jian)安排(pai)。版(ban)面費不祥(xiang)。該(gai)雜(za)(za)志(zhi)近兩年(nian)未被列(lie)入(ru)預(yu)警(jing)名單,建議您投(tou)(tou)稿(gao)(gao)(gao)。如您想(xiang)(xiang)了(le)解(jie)更多投(tou)(tou)稿(gao)(gao)(gao)政策及投(tou)(tou)稿(gao)(gao)(gao)方案,請咨(zi)詢(xun)客服。
若用戶需要出版服務(wu),請聯系(xi)出版商。